Form 4 Filing for Phyllis R. Yale at Bristol Myers Squibb Co.

Phyllis R. Yale, a director at Bristol Myers Squibb Co. (BMY), reported a transaction on June 30, 2026. The transaction involved acquiring 607.428 Deferred Share Units at a price of $57.62 per unit. These units are convertible into shares of common stock upon settlement, which occurs when Yale ceases to be a director or at a previously specified future date. Following this transaction, Yale holds 44,986.288 Deferred Share Units. This total includes deferred compensation and reinvested dividends under the 1987 Deferred Compensation Plan for Non-Employee Directors. The filing is a Form 4, indicating a change in beneficial ownership.